日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis.

Protectin DX 通过激活肌细胞因子-肝脏葡萄糖调节轴来缓解胰岛素抵抗

White Phillip J, St-Pierre Philippe, Charbonneau Alexandre, Mitchell Patricia L, St-Amand Emmanuelle, Marcotte Bruno, Marette André

Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance

诺比列汀可减轻饮食诱导的胰岛素抵抗小鼠的极低密度脂蛋白过度生成、血脂异常和动脉粥样硬化。

Mulvihill, Erin E; Assini, Julia M; Lee, Justin K; Allister, Emma M; Sutherland, Brian G; Koppes, Julie B; Sawyez, Cynthia G; Edwards, Jane Y; Telford, Dawn E; Charbonneau, Alexandre; St-Pierre, Philippe; Marette, André; Huff, Murray W